Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
196170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7196170005
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
- Website:
- http://www.alteogen.com/
Description
Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-10 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-13 00:00 |
반기보고서 (2025.06)
|
Korean | 2.1 MB | ||
| 2025-05-21 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-05-13 00:00 |
분기보고서 (2025.03)
|
Korean | 2.1 MB | ||
| 2025-04-30 00:00 |
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-03 00:00 |
회사합병결정(종속회사의주요경영사항)
|
Korean | 19.8 KB | ||
| 2025-04-03 00:00 |
타법인주식및출자증권취득결정
|
Korean | 16.6 KB | ||
| 2025-04-03 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 117.7 KB | ||
| 2025-03-31 00:00 |
정기주주총회결과
|
Korean | 25.6 KB | ||
| 2025-03-31 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.1 KB | ||
| 2025-03-26 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-03-21 00:00 |
감사보고서제출
|
Korean | 25.1 KB | ||
| 2025-03-21 00:00 |
사업보고서 (2024.12)
|
Korean | 583.5 KB | ||
| 2025-03-17 00:00 |
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
|
Korean | 11.2 KB | ||
| 2025-03-17 00:00 |
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
|
Korean | 11.2 KB |
Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alteogen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alteogen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
